Silo Pharma, Inc. Logo

Silo Pharma, Inc.

Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.

SILO | US

Overview

Corporate Details

ISIN(s):
US82711P2011 (+1 more)
LEI:
Country:
United States of America
Address:
677 N. WASHINGTON BLVD, 34236 SARASOTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Silo Pharma, Inc. is a developmental-stage biopharmaceutical company focused on creating novel formulations of traditional and psychedelic therapeutics. The company targets underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. Its portfolio includes programs such as SPC-15 for PTSD and SP-26 for fibromyalgia, as well as preclinical assets for Alzheimer’s disease and multiple sclerosis. Silo Pharma utilizes the streamlined 505(b)(2) regulatory pathway to potentially lower costs and accelerate FDA approval. The company develops its intellectual property through exclusive collaborations with leading universities and research partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Silo Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Silo Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Silo Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden
DVYSR
DiaMedica Therapeutics Inc. Logo
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America
DMAC
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden
DMYD
Dianthus Therapeutics, Inc. /DE/ Logo
Developing selective antibody therapies for severe autoimmune diseases.
United States of America
DNTH
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy
DIA
Disc Medicine, Inc. Logo
Developing novel therapies for patients with serious hematologic and rare blood disorders.
United States of America
IRON
DONG-A ST CO.,LTD Logo
Develops and distributes ethical drugs, medical devices, and diagnostics for global healthcare.
South Korea
170900
DongKoo Bio & Pharma Co., Ltd. Logo
Pharma leader in dermatology, developing treatments, probiotics, and investing in biotech therapies.
South Korea
006620
DongKook Life Science Co., Ltd. Logo
A pharmaceutical firm specializing in contrast media for diagnostic imaging and medical devices.
South Korea
303810
DongKookPharmaceuticalCo.,Ltd. Logo
Develops, manufactures, and distributes pharmaceuticals and healthcare products globally.
South Korea
086450

Talk to a Data Expert

Have a question? We'll get back to you promptly.